Antisense interleukin 10 and methods of use
AssigneeUniversity of Medicine and Dentistry of New Jersey
InventorElizabeth S. Raveché
Life of this patent
Estimating the term…
Abstract
The present invention pertains to a method for treating a patient with a disease in which the levels of interleukin-10 need to be down-regulated which comprises adminstering to the patient a therapeutically effective amount of an antisense oligodeoxynucleotide specific for interleukin-10 mRNA. The present invention also pertains to an antisense oligodeoxynucleotide specific for interleukin-10 mRNA having the formula 5′-TGGGTCTTGGTTCTCAGCTTGGGGCAT (SEQ ID NO:1).
Claims1
An antisense oligodeoxynucleotide specific for interleukin-10 mRNA consisting of the formula 5′-TGGGTCTTGGTTCTCAGCTTGGGGCAT (SEQ ID NO:
- 1).
Dependencies are inferred from the claim text.